Leviathan Therapeutics
Waltham, US · Founded 2022 · Delaware corporation
Founders & leadership
BG
Brian GastmanNamed on SEC filing
ML
Melissa LokugamageNamed on SEC filing
LM
Lauren MifflinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2022
▶$250KraisedJul 2022 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJul 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian GastmanDirector
- Melissa LokugamageDirector
- Lauren MifflinExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $250K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Leviathan Therapeutics raised?
- Leviathan Therapeutics has disclosed $250K raised across 1 round.
- Where is Leviathan Therapeutics headquartered?
- Leviathan Therapeutics is headquartered in Waltham, US.